Welcome - AML18 Pilot Trial
The AML18 Pilot Trial is a collaborative trial in acute myeloid leukaemia primarily for patients over 60 years, which is being undertaken by the NCRI Haematological Oncology Study Group centres under the auspices of the Cardiff Experimental Cancer Medicine Centre (ECMC) and sponsorship of Cardiff University.
Please click the links below for further information about our collaborators.
 |
 |
 |